Aspect Partners »

Immix Biopharma shares owned by Aspect Partners

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Aspect Partners from 13F filings

Historical chart of Aspect Partners investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Aspect Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Aspect Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $81 9 9.11

More positions owned by Aspect Partners

Vanguard Total Stock Market Etf Etf (VTI)
Ishares Msci Eafe Small-cap Etf Etf (SCZ)
State Street Spdr S&p 500 Etf Etf (SPY)
Ishares Core Msci Eafe Etf Etf (IEFA)
Alpha Architect 1-3 Month Box Etf Etf (BOXX)
Invesco Optimum Yield Diversified Commodity Strategy No K-1 Etf Etf (PDBC)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Spdr Gold Shares Etf (GLD)
Ishares International Treasury Bond Etf Etf (IGOV)
Ishares Core S&p Small Cap Etf Etf (IJR)
Return Stacked Global Stocks & Bonds Etf Etf (RSSB)
Ishares Gold Trust Etf (IAU)
Distillate Small/mid Cash Flow Etf Etf (DSMC)
State Street Real Estate Select Sector Spdr Etf Etf (XLRE)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)

View all positions for Aspect Partners

Top funds holding Immix Biopharma

Saturn V Capital Management
Eventide Asset Management
Marshall Wace
Millennium Management
Adage Capital Partners GP
Vanguard Group
Logos Global Management
Bleichroeder
Blue Owl Capital Holdings
Franklin Resources
Susquehanna International
Ameriprise Financial
Perceptive Advisors
Burkehill Global Management
Renaissance Technologies

View all funds holding Immix Biopharma